Field evaluation of efficacy and tolerance of a 2% marbofloxacin injectable solution for the treatment of respiratory disease in fattening pigs
作者:
E. Thomas,
E. Grandemange,
P. Pommier,
S. Wessel‐Robert,
J.L. Davot,
期刊:
Veterinary Quarterly
(Taylor Available online 2000)
卷期:
Volume 22,
issue 3
页码: 131-135
ISSN:0165-2176
年代: 2000
DOI:10.1080/01652176.2000.9695041
出版商: Taylor & Francis Group
关键词: Pigs;marbolloxacin;field trial;antibiotherapy;pneumonia;respiratory disease
数据来源: Taylor
摘要:
In a controlled and randomized field trial carried out in three European countries, 219 fattening pigs, from seven farms with respiratory disease problems, were treated intramuscularly for three or five days either with marbofloxacin 2 mg/kg/day, or with amoxicillin 7 mg/kg/day. Pigs were monitored daily until D5 (Day 5) and again at D21, and were weighed at D0 and D21.Pasteurella multocida,Actinobacillus pleuropneumoniae, andMycoplasma hyopneumoniaewere mainly identified in the pig lungs. The difference in the cure rate (74.5% in marbofloxacin groupversus68% in the amoxicillin group) was not significant. Mean rectal temperature was significantly lower after treatment with marbofloxacin. Other criteria tended to be favourable for the marbofloxacin group, although differences were not significant. The time to cure tended to be shorter for the marbofloxacin group (24.3% of pigs at 24 hours post‐treatmentversus12.1% in the amoxicillin group). Marbofloxacin and amoxicillin relapse rates were 11.9% and 17.2% respectively (not significant) and daily weight gain was 746 g in the marbofloxacin groupversus687 g in the amoxicillin group (not significant). The 2% marbofloxacin solution was significantly better tolerated than amoxicillin.
点击下载:
PDF (1648KB)
返 回